PNC Financial Services Group’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28K Sell
12,715
-54
-0.4% -$119 ﹤0.01% 3414
2025
Q1
$14.8K Buy
12,769
+4,334
+51% +$5.03K ﹤0.01% 3678
2024
Q4
$10.7K Buy
8,435
+647
+8% +$822 ﹤0.01% 3779
2024
Q3
$26.6K Buy
7,788
+772
+11% +$2.63K ﹤0.01% 3380
2024
Q2
$32.8K Sell
7,016
-23,210
-77% -$108K ﹤0.01% 3246
2024
Q1
$224K Sell
30,226
-13
-0% -$96 ﹤0.01% 2086
2023
Q4
$306K Sell
30,239
-425
-1% -$4.31K ﹤0.01% 1845
2023
Q3
$239K Sell
30,664
-200
-0.6% -$1.56K ﹤0.01% 1988
2023
Q2
$254K Sell
30,864
-72
-0.2% -$593 ﹤0.01% 2038
2023
Q1
$224K Hold
30,936
﹤0.01% 2078
2022
Q4
$274K Hold
30,936
﹤0.01% 1922
2022
Q3
$379K Buy
30,936
+125
+0.4% +$1.53K ﹤0.01% 1681
2022
Q2
$364K Sell
30,811
-11,000
-26% -$130K ﹤0.01% 1733
2022
Q1
$795K Buy
41,811
+19,594
+88% +$373K ﹤0.01% 1373
2021
Q4
$590K Sell
22,217
-10,974
-33% -$291K ﹤0.01% 1586
2021
Q3
$1.36M Sell
33,191
-3
-0% -$123 ﹤0.01% 1045
2021
Q2
$1.88M Sell
33,194
-461
-1% -$26.1K ﹤0.01% 940
2021
Q1
$1.41M Buy
33,655
+372
+1% +$15.6K ﹤0.01% 1027
2020
Q4
$2.33M Buy
33,283
+2,832
+9% +$199K ﹤0.01% 798
2020
Q3
$854K Buy
30,451
+371
+1% +$10.4K ﹤0.01% 1106
2020
Q2
$890K Sell
30,080
-14,134
-32% -$418K ﹤0.01% 1086
2020
Q1
$876K Buy
44,214
+4,532
+11% +$89.8K ﹤0.01% 1027
2019
Q4
$1.18M Buy
39,682
+800
+2% +$23.7K ﹤0.01% 1032
2019
Q3
$884K Sell
38,882
-2,632
-6% -$59.8K ﹤0.01% 1312
2019
Q2
$1.03M Sell
41,514
-88
-0.2% -$2.18K ﹤0.01% 1271
2019
Q1
$1.02M Buy
41,602
+10,323
+33% +$252K ﹤0.01% 1284
2018
Q4
$711K Buy
31,279
+30,177
+2,738% +$686K ﹤0.01% 1382
2018
Q3
$35K Buy
1,102
+2
+0.2% +$64 ﹤0.01% 3207
2018
Q2
$39K Sell
1,100
-200
-15% -$7.09K ﹤0.01% 3144
2018
Q1
$43K Buy
1,300
+988
+317% +$32.7K ﹤0.01% 3048
2017
Q4
$10K Buy
+312
New +$10K ﹤0.01% 3682
2016
Q3
Sell
-59
Closed -$1K 4056
2016
Q2
$1K Buy
+59
New +$1K ﹤0.01% 4340